Mergers & Acquisitions
By The Online Investor Staff, updated Fri., Apr. 19, 2:45 PM
Slide #49. Ginkgo Bioworks — AgBiome's Platform Assets
Acquirer: |
Ginkgo Bioworks (NYSE:DNA) |
Acquiree: |
AgBiome's Platform Assets |
Details: |
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline. These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022, and will expand Ginkgo's proprietary unified metagenomics database. Combined, this creates one of the deepest and most advanced ag biological discovery and development platforms as well as a rich resource for the development of AI models for biological R&D. |
Ginkgo Bioworks Holdings develops a platform for programming cells to enable customers to utilize biology to create products across various industries. Co.'s platform includes equipment, robotic automation, software, data pipelines and tools, and operating procedures for throughput genetic engineering, fermentation, and analytics (referred to collectively as the Foundry); and a library of proprietary genetic assets and associated performance data (referred to collectively as Codebase).
DNA SEC Filing Email Alerts Service
Open the DNA Page at The Online Investor »
Company Name: |
Ginkgo Bioworks Holdings Inc |
Sector: |
Specialty Chemicals |
Number of ETFs Holding DNA: |
33 |
Total Market Value Held by ETFs: |
$288.27M |
Total Market Capitalization: |
$1.44B |
% of Market Cap. Held by ETFs: |
20.03% |
|
Open the DNA Page at The Online Investor (in a new window) »
|
April 19, 2024 2:45 PM Eastern
Hold (1.86 out of 4)
100th percentile
|
|